CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo

CIZZLE BIOTECHNOLOGY HOLDINGS PLC

Developing a CIZ1B biomarker blood test for the early detection of lung cancer.

CIZ | IL

Overview

Corporate Details

ISIN(s):
GB00BNG2VN02
LEI:
213800G3OS3SA2J1Y358
Country:
United Kingdom
Address:
6TH FLOOR, 60 GRACECHURCH STREET, EC3V 0HR LONDON
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Cizzle Biotechnology Holdings PLC is a diagnostics company developing a non-invasive blood test for the early detection of lung cancer. The company's core product utilizes its proprietary CIZ1B biomarker, an advanced immunoassay designed to identify lung cancer at its earliest, most treatable stages with high sensitivity. This cost-effective solution aims to streamline the diagnostic pathway for healthcare providers, reducing reliance on CT scans and minimizing unnecessary invasive follow-up procedures. Originating as a spin-out from the University of York, Cizzle is advancing its technology through global clinical trials to secure regulatory approval and improve patient outcomes worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-18 08:00
Regulatory News Service
Commercial Progress in USA
English 22.0 KB
2025-07-08 10:40
Annual Report
Annual Report for the year ended 31 December 2024
English 332.7 KB
2025-06-06 12:00
Report Publication Announcement
Notice of AGM
English 11.4 KB
2025-05-28 08:00
Major Shareholding Notification
Holding(s) in Company
English 51.1 KB
2025-03-25 08:00
Board/Management Information
Appointment of Non-Executive Director
English 15.7 KB
2025-01-02 08:00
Board/Management Information
Appointment of Professor Dawn Coverley as CSO
English 17.8 KB
2024-12-16 08:00
M&A Activity
Update on Strategic Partnership in North America
English 23.8 KB
2024-10-21 08:00
M&A Activity
Execution of Agreement for North America
English 25.9 KB
2024-10-03 14:12
Regulatory News Service
Update on Licensing and Partnership Agreement
English 10.6 KB
2024-09-30 08:00
Interim Report
Interim Results
English 208.3 KB
2024-09-16 08:00
Major Shareholding Notification
Holding(s) in Company
English 37.5 KB
2024-09-09 08:00
Regulatory News Service
Collaboration with Moffitt Cancer Center
English 25.0 KB
2024-07-25 08:00
Business and Financial Review
Update on Strategic Partnership in North America
English 15.2 KB
2024-07-18 08:00
M&A Activity
Manufacturing Agreement with BBI Solutions
English 21.1 KB
2024-07-09 08:00
Remuneration Information
Issue of Share Options in Lieu of Consultancy Fees
English 14.0 KB

Automate Your Workflow. Get a real-time feed of all CIZZLE BIOTECHNOLOGY HOLDINGS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CIZZLE BIOTECHNOLOGY HOLDINGS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.